| Literature DB >> 26037234 |
Nobuhiro Mizuno1, Eiji Nishibori2, Mitsuru Oka3, Takahito Jomori4, Masaki Takata5,6, Takashi Kumasaka1.
Abstract
Of organogermanium compounds known to have an immunostimulatory action, propagermanium [PGe; 3-oxygermylpropionic acid polymer, (C3 H5 GeO3.5 )n] is the only one used as a pharmaceutical agent, to treat the hepatitis B virus in Japan. However, because of lack of information about its structure, PGe has been confused with a polymeric solid, repagermanium (RGe, Ge-132, poly-trans-[(2-carboxyethyl) germasesquioxane], (C18 H30 Ge6 O21 )n), which has the same essential formula as PGe. To clarify this issue, the structure of PGe was analyzed using X-ray diffraction (XRD). PGe has a polymeric ladder-shaped structure of a concatenated eight-membered ring composed of Ge-O bonds, which is clearly distinguished from the infinite sheet structure in RGe. Moreover, we observed temperature or moisture-dependent transformations among these compounds using powder XRD. For instance, PGe was easily dissolved in water, and transformed to RGe by exposure to water vapor, but transformed into another straight-chain structure when exposed to aqueous solution. As a result of these findings, PGe was indicated to have labile polymer packing against RGe. These characteristics of PGe may affect pharmaceutical properties such as respective stability and solubility, which indicate its unique impact on physiological activity.Entities:
Keywords: X-ray powder diffractometry; crystal structure; crystallography; solvation; stability
Mesh:
Substances:
Year: 2015 PMID: 26037234 DOI: 10.1002/jps.24486
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534